...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Phase 3 Design

When the Phase 3 trial was initially designed, do we know what the assumed MACE rate for the placebo and the dosed patient group was?  They assumed the trial would finish by November 2018, so clearly something in their assumptions went haywire.

Share
New Message
Please login to post a reply